Intracoronary Infusion of Bone Marrow-Derived Mononuclear Cells Abrogates Adverse Left Ventricular Remodelling Post-Acute Myocardial Infarction: Insights from the Reinfusion of Enriched Progenitor Cells and Infarct Remodelling in Acute Myocardial Infarction (REPAIR-AMI) Trial

Abstract

Intracoronary administration of BMC eliminates the correlation between depressed LVEF after reperfusion therapy and LV expansion during follow-up and, thereby, abrogates early LV remodelling after AMI.